BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 16049096)

  • 1. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.
    Schouten JA; Hulscher ME; Kullberg BJ; Cox A; Gyssens IC; van der Meer JW; Grol RP
    J Antimicrob Chemother; 2005 Sep; 56(3):575-82. PubMed ID: 16049096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.
    Schouten JA; Hulscher ME; Trap-Liefers J; Akkermans RP; Kullberg BJ; Grol RP; van der Meer JW
    Clin Infect Dis; 2007 Apr; 44(7):931-41. PubMed ID: 17342644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
    Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
    Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Centers for Medicare and Medicaid Services (CMS) community-acquired pneumonia core measures lead to unnecessary antibiotic administration by emergency physicians.
    Nicks BA; Manthey DE; Fitch MT
    Acad Emerg Med; 2009 Feb; 16(2):184-7. PubMed ID: 19133854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort.
    Wu JH; Howard DH; McGowan JE; Turpin RS; Henry Hu X
    Clin Ther; 2006 Sep; 28(9):1451-61. PubMed ID: 17062317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia.
    Blot SI; Rodriguez A; Solé-Violán J; Blanquer J; Almirall J; Rello J;
    Crit Care Med; 2007 Nov; 35(11):2509-14. PubMed ID: 17901833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of treatment guidelines to support judicious use of antibiotic therapy.
    Deuster S; Roten I; Muehlebach S
    J Clin Pharm Ther; 2010 Feb; 35(1):71-8. PubMed ID: 20175814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
    Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
    Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study.
    Capelastegui A; España PP; Quintana JM; Gorordo I; Ortega M; Idoiaga I; Bilbao A
    Clin Infect Dis; 2004 Oct; 39(7):955-63. PubMed ID: 15472846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study.
    Schouten JA; Hulscher ME; Natsch S; Kullberg BJ; van der Meer JW; Grol RP
    Qual Saf Health Care; 2007 Apr; 16(2):143-9. PubMed ID: 17403764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of emergency department crowding on time to antibiotics in patients admitted with community-acquired pneumonia.
    Fee C; Weber EJ; Maak CA; Bacchetti P
    Ann Emerg Med; 2007 Nov; 50(5):501-9, 509.e1. PubMed ID: 17913300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of indicators to evaluate the quality of community-acquired pneumonia management.
    Nathwani D; Williams F; Winter J; Winter J; Ogston S; Davey P
    Clin Infect Dis; 2002 Feb; 34(3):318-23. PubMed ID: 11774078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a simple educational intervention on the hospital management of community-acquired pneumonia.
    Serisier DJ; Bowler SD
    Respirology; 2007 May; 12(3):389-93. PubMed ID: 17539843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective use of blood cultures in emergency department pneumonia patients.
    Benenson RS; Kepner AM; Pyle DN; Cavanaugh S
    J Emerg Med; 2007 Jul; 33(1):1-8. PubMed ID: 17630066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Sep; 12(5):754-8. PubMed ID: 17875067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An emergency department-based randomized trial of nonbronchoscopic bronchoalveolar lavage for early pathogen identification in severe community-acquired pneumonia.
    Rodriguez RM; Fancher ML; Phelps M; Hawkins K; Johnson J; Stacks K; Rossini T; Way M; Holland D
    Ann Emerg Med; 2001 Oct; 38(4):357-63. PubMed ID: 11574790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Questionnaire survey of guideline implementation for community acquired pneumonia with retrospective analysis of the empiric treatment in 490 patients].
    Xu ZJ; Ding K; Huang H; Sun TY; Ke HX; Tong ZH; Wei TN; Peng K; Yao B; Li FX; Liu JH; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):442-6. PubMed ID: 17673019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia.
    Schouten JA; Prins JM; Bonten MJ; Degener J; Janknegt RE; Hollander JM; Jonkers RE; Wijnands WJ; Verheij TJ; Sachs AP; Kullberg BJ;
    Neth J Med; 2005 Sep; 63(8):323-35. PubMed ID: 16186645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.